English | 简体中文 | 繁體中文 | 한국어 | 日本語
Saturday, 27 February 2021, 11:00 HKT/SGT
Share:
    

Source: ROK-Biotech
ROK-Biotech, Korea's leading cosmetic brand, Launches the new product 'Dr. M-KIN Anti V Hand Cream'

The demand for natural cosmetics has been increasing during Covid-19 throughout the world.

The pandemic has also resulted in a change in people's habits and has led to a greater demand for a natural product with functional properties including many types of household items and food.

A South Korean cosmetic brand ROK-Biotech is gaining attention for its natural functional products giving excellent antibacterial and antiviral effects; they have recently developed the products using a molecular biology tool.

Their new product Dr. M-KIN Anti-V Hand Cream launched in January 2021 is a multifunctional all-in-one product that provides hand sterilization and skin protection with a moisturizing effect.

The product went through a series of tests from the Korea Testing & Research Institute (KTR) and the antibacterial test results showed it kills 99.9% of germs (5 different bacteria was used); the antiviral test results showed it was 99% effective against Human Respiratory Syncytial Virus (RSV). On top of that, the results of the Skin Irritation Test (SIT) showed that the product is classified in non-irritation category (0.00). This data further proves that the product is perfectly safe for the human skin. ROK-Biotech found out that sanitizers (70% ethanol) that we use every day, cause hands to become dry, while also causing other negative effects to our hands. In order to solve this problem, they developed Dr. M-KIN Anti-V Hand Cream. This company paid a lot of attention to the moisturizing effect by strengthening hyaluronic acid and ceramide ingredients for dry hand skincare. This product is perfect to use in the winter season as Centella Asiatica extract contained in the product helps your skin recover from frostbites (cold shock).

ROK-Biotech's M-KIN is a blended word made by combining words 'Miracle+Skin', meaning Creates miracle products for your skin. With their unique technology for natural ingredients, they developed a hypoallergenic product for all types of skin including sensitive skin. The Korea Testing & Research Institute (KTR), has proved it to be effective in reducing excess sebum and oil, improving blemishes and skin texture.

It has applied the company's research data and objective verification regarding the functionality of natural oriental ingredients such as Coptis Chinensis and Anthriscus sylvestris extract in new products.

They pursue their own path as a cosmetic brand specializing in natural oriental ingredients that don't cause skin irritation.

M-KIN products are natural functional cosmetics with an excellent sebum control ability as well as anti-inflammatory and antibacterial effects, containing berberine extracted from Coptis Chinensis. They said they were able to find various natural functional materials as a result of continuous investment in R&D in order to find out new technologies for functional natural ingredient development.

Meanwhile, ROK-Biotech has announced that they are planning to launch a new item during the second half of 2021. They're currently working on research to develop cosmetic materials utilizing stem cell-derived exosomes with Biopharmaceutical Research Center located in Jeollanam-do, South Korea. As they're actively gaining investors and holding meetings with potential buyers, we are looking forward to seeing how they progress in 2021.

Media contact

Contact: Ph.D. Sang-Rok Lee, CEO
E-mail: rok94@hanmail.net
Telephone: +82-61-373-5959, +82-10-2602-5957
Website: http://www.m-kin.com/



Topic: Press release summary
Source: ROK-Biotech


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Toyota Yaris WRC Returns to Home Roads for an Autumn Rally Finland  
Sept 24, 2021 19:30 HKT/SGT
Xilinx and NEC Accelerate Next-Generation 5G Radio Units for Global Deployment   
Sept 24, 2021 18:22 HKT/SGT
Mitsui Chemicals Teams up With NEC and dotData to Trial AI-based Price Change Forecasting for Market-Sensitive Products  
Sept 24, 2021 18:00 HKT/SGT
Moonstake Joins Hyper Protect Accelerator, A Startup Incubator Program of IBM  
Sept 24, 2021 11:00 HKT/SGT
Justin Sun: Preserve the Blockchain Spirit of Compliance and Transparency  
Sept 24, 2021 10:00 HKT/SGT
Fujitsu Sources 100% of Energy Needs for Global HQ from Renewables  
Sept 24, 2021 09:50 HKT/SGT
Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research  
Sept 24, 2021 09:00 HKT/SGT
Honda and Google Collaborate on In-vehicle Connected Services   
Sept 24, 2021 08:16 HKT/SGT
Animoca Brands uses Blockpass' On-chain KYC(TM) to verify NFT prize winners  
Sept 24, 2021 08:00 HKT/SGT
ACROMEC's associate Life Science Incubator launches Co-working Labspace  
Sept 24, 2021 07:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575